- Home
- NRDY vs LXEO Comparison
NRDY vs LXEO Comparison
Compare NRDY & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- LXEO
- Stock Information
- Founded
- NRDY 2007
- LXEO 2017
- Country
- NRDY United States
- LXEO United States
- Employees
- NRDY N/A
- LXEO N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- LXEO
- Sector
- NRDY Technology
- LXEO
- Exchange
- NRDY Nasdaq
- LXEO Nasdaq
- Market Cap
- NRDY 191.6M
- LXEO 140.6M
- IPO Year
- NRDY N/A
- LXEO 2023
- Fundamental
- Price
- NRDY $1.49
- LXEO $2.97
- Analyst Decision
- NRDY Hold
- LXEO Strong Buy
- Analyst Count
- NRDY 8
- LXEO 5
- Target Price
- NRDY $1.90
- LXEO $23.80
- AVG Volume (30 Days)
- NRDY 1.3M
- LXEO 475.1K
- Earning Date
- NRDY 05-06-2025
- LXEO 03-18-2025
- Dividend Yield
- NRDY N/A
- LXEO N/A
- EPS Growth
- NRDY N/A
- LXEO N/A
- EPS
- NRDY N/A
- LXEO N/A
- Revenue
- NRDY $190,231,000.00
- LXEO N/A
- Revenue This Year
- NRDY $4.59
- LXEO N/A
- Revenue Next Year
- NRDY $9.87
- LXEO N/A
- P/E Ratio
- NRDY N/A
- LXEO N/A
- Revenue Growth
- NRDY N/A
- LXEO N/A
- 52 Week Low
- NRDY $0.73
- LXEO $2.32
- 52 Week High
- NRDY $3.28
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- NRDY 35.02
- LXEO 37.57
- Support Level
- NRDY $1.44
- LXEO $2.51
- Resistance Level
- NRDY $1.65
- LXEO $2.95
- Average True Range (ATR)
- NRDY 0.12
- LXEO 0.34
- MACD
- NRDY -0.01
- LXEO 0.07
- Stochastic Oscillator
- NRDY 51.04
- LXEO 40.88
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.